Miglustat Capsule
Product Images NDC 43975-310

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Miglustat (NDC 43975-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

MIGLUSTAT 100 mg oral capsules carton with NDC 43975-310-83. The label indicates 90 unit-of-use capsules (15 x 6). Manufactured by Suzhou Amerigen Pharmaceutical Co. Ltd and distributed by ANI Pharmaceuticals, Inc. The label highlights the Rx-only status and oral use route, featuring black text on white background with blue lines framing the product name and strength.*

FDA Label Image

Structure (Structure)

Chemical structure of Miglustat showing a hexahydroazepine ring with hydroxyl groups and a methyl substitution, as seen in the active ingredient Miglustat capsules by ANI Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.